Literature DB >> 21442444

The role of p63 in cancer, stem cells and cancer stem cells.

Marta Nekulova1, Jitka Holcakova, Philip Coates, Borivoj Vojtesek.   

Abstract

The transcription factor p63 has important functions in tumorigenesis, epidermal differentiation and stem cell self-renewal. The TP63 gene encodes multiple protein isoforms that have different or even antagonistic roles in these processes. The balance of p63 isoforms, together with the presence or absence of the other p53 family members, p73 and p53, has a striking biological impact. There is increasing evidence that interactions between p53-family members, whether cooperative or antagonistic, are involved in various cell processes. This review summarizes the current understanding of the role of p63 in tumorigenesis, metastasis, cell migration and senescence. In particular, recent data indicate important roles in adult stem cell and cancer stem cell regulation and in the response of cancer cells to therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442444      PMCID: PMC6275999          DOI: 10.2478/s11658-011-0009-9

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  176 in total

Review 1.  The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.

Authors:  Lakshmanane Boominathan
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

2.  Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes.

Authors:  David Christopher Harmes; Edward Bresnick; Emma A Lubin; Julie K Watson; Kelly E Heim; Joshua C Curtin; Anne M Suskind; Justin Lamb; James DiRenzo
Journal:  Oncogene       Date:  2003-10-23       Impact factor: 9.867

3.  RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.

Authors:  Alexey Fomenkov; Rachel Zangen; Yi-Ping Huang; Motonobu Osada; Zhongmin Guo; Tanya Fomenkov; Barry Trink; David Sidransky; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2004-10-06       Impact factor: 4.534

4.  Self-renewal of the adult skeletal muscle satellite cell.

Authors:  Charlotte A Collins; Terence A Partridge
Journal:  Cell Cycle       Date:  2005-10-23       Impact factor: 4.534

5.  Perp is a p63-regulated gene essential for epithelial integrity.

Authors:  Rebecca A Ihrie; Michelle R Marques; Bichchau T Nguyen; Jennifer S Horner; Cristian Papazoglu; Roderick T Bronson; Alea A Mills; Laura D Attardi
Journal:  Cell       Date:  2005-03-25       Impact factor: 41.582

6.  p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.

Authors:  M Dohn; S Zhang; X Chen
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

7.  The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

Authors:  Isabella Manni; Simona Artuso; Silvia Careccia; Maria Giulia Rizzo; Renato Baserga; Giulia Piaggio; Ada Sacchi
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

8.  Evaluation of p63 and p73 antibodies for cross-reactivity.

Authors:  Jennifer M Rosenbluth; Kimberly Johnson; Luojia Tang; Tracy Triplett; Jennifer A Pietenpol
Journal:  Cell Cycle       Date:  2009-11-09       Impact factor: 4.534

9.  p63 induces key target genes required for epidermal morphogenesis.

Authors:  Maranke I Koster; Daisy Dai; Barbara Marinari; Yuji Sano; Antonio Costanzo; Michael Karin; Dennis R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

10.  Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.

Authors:  A Petitjean; C Ruptier; V Tribollet; A Hautefeuille; F Chardon; C Cavard; A Puisieux; P Hainaut; C Caron de Fromentel
Journal:  Carcinogenesis       Date:  2007-11-28       Impact factor: 4.944

View more
  37 in total

1.  ΔNp63α represses anti-proliferative genes via H2A.Z deposition.

Authors:  Corrie L Gallant-Behm; Matthew R Ramsey; Claire L Bensard; Ignacio Nojek; Jack Tran; Minghua Liu; Leif W Ellisen; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2012-09-26       Impact factor: 11.361

2.  ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas.

Authors:  Christopher G Abraham; Michael P Ludwig; Zdenek Andrysik; Ahwan Pandey; Molishree Joshi; Matthew D Galbraith; Kelly D Sullivan; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2018-09-18       Impact factor: 9.423

3.  Nuclear p63 expression in osteoblastic tumors.

Authors:  Michael E Kallen; Melinda E Sanders; Adriana L Gonzalez; Jennifer O Black; Vicki L Keedy; Kenneth R Hande; Kelly C Homlar; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Cheryl M Coffin; Justin M M Cates
Journal:  Tumour Biol       Date:  2012-05-25

4.  Occasional staining for p63 in malignant vascular tumors: a potential diagnostic pitfall.

Authors:  Michael E Kallen; Flavia G Nunes Rosado; Adriana L Gonzalez; Melinda E Sanders; Justin M M Cates
Journal:  Pathol Oncol Res       Date:  2011-06-13       Impact factor: 3.201

5.  TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.

Authors:  Michaela Galoczova; Rudolf Nenutil; Zuzana Pokorna; Borivoj Vojtesek; Philip J Coates
Journal:  Virchows Arch       Date:  2020-10-10       Impact factor: 4.064

Review 6.  Stem cells and the developing mammary gland.

Authors:  Maisam Makarem; Benjamin T Spike; Christopher Dravis; Nagarajan Kannan; Geoffrey M Wahl; Connie J Eaves
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-04-27       Impact factor: 2.673

7.  Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.

Authors:  Marta Nekulova; Jitka Holcakova; Rudolf Nenutil; Rembert Stratmann; Pavla Bouchalova; Petr Müller; Lucie Mouková; Philip J Coates; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2013-07-26       Impact factor: 4.064

Review 8.  Therapeutic targeting of the p53 pathway in cancer stem cells.

Authors:  Varun V Prabhu; Joshua E Allen; Bo Hong; Shengliang Zhang; Hairong Cheng; Wafik S El-Deiry
Journal:  Expert Opin Ther Targets       Date:  2012-09-24       Impact factor: 6.902

Review 9.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

10.  Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.

Authors:  Ming-Yang Li; Lin-Ni Fan; Dong-Hui Han; Zhou Yu; Jing Ma; Yi-Xiong Liu; Pei-Feng Li; Dan-Hui Zhao; Jia Chai; Lei Jiang; Shi-Liang Li; Juan-Juan Xiao; Qiu-Hong Duan; Jing Ye; Mei Shi; Yong-Zhan Nie; Kai-Chun Wu; Dezhong Joshua Liao; Yu Shi; Yan Wang; Qing-Guo Yan; Shuang-Ping Guo; Xiu-Wu Bian; Feng Zhu; Jian Zhang; Zhe Wang
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.